Skip to main content
| News

Canton of Basel-Landschaft cuts corporate tax rates

25.11.2019

Corporate tax rates in the canton of Basel-Landschaft will be cut from a maximum of 20.7 percent today to 13.45 percent in 2025. This has been stipulated by the proposed Tax Regulation 17, which was approved on Sunday.

Business location Baselland (img: Schärli Hölstein)

Corporate tax rates in the canton of Basel-Landschaft will be cut markedly. The proposed Tax Regulation 17 stipulates that tax on earnings is to be reduced in five steps from the maximum level of 20.7 percent today to 13.45 percent by 2025. Tax on capital will be halved for all companies from the current level of 3.8 per thousand to 1.6 per thousand. In addition, the canton is to introduce a patent box for earnings generated by patents and similar rights; this will offer relief of up to 90 percent. Moreover, an additional discount of 20 percent is offered to research and development activities. At the same time, the tax cut for childcare offered by third parties has been increased to 10,000 Swiss francs and cantonal funding for premiums with individual reductions has been raised by 17.4 million francs.

On Sunday, a clear majority of 63.2 percent of voters approved the proposed tax regulation. In the district of Arlesheim (a suburb of Basel), the majority even hit 66.3 percent. The new cantonal tax regulation implements the Federal Act on Tax Reform and OASI Funding approved by the Swiss people back in May. This will eliminate the previous tax benefits for holding companies. Before, companies benefitting from this fiscal circumstance had been paying 10-11 percent in tax on earnings.

The Basel Chamber of Commerce (HKBB) welcomed the results of voting. “Voters in the Basel-Landschaft area have recognized that the taxation proposal strengthens the region”, HKBB Director Martin Dätwyler commented in a press release. The broad level of support from parties and associations all the way down to individual municipalities shows that a proposal had been negotiated that would command a majority.

Share this article

Sign up to receive our newsletter in your inbox.

You might also be interested in

BeiGene opens European headquarters in Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

BeiGene opens European headquarters in Basel

BeiGene has opened its new European headquarters in Basel. The global biotech specializing in innovative cancer treatments intends to build...

Read More
The 25 Best AI Courses in the Basel Area, Germany and France
Advanced Manufacturing/AI, Basel Area Business & Innovation, Innovation

The 25 Best AI Courses in the Basel Area, Germany and France

Artificial Intelligence (AI) offers numerous possible applications. But how, where and regarding which focal points can you get further training...

Read More
Engimmune Therapeutics banks 15.5 million Swiss francs
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Engimmune Therapeutics banks 15.5 million Swiss francs

Engimmune Therapeutics will now be in a position to drive forward its innovative platforms for the development of T-cell therapies...

Read More
Bionter receives 3 million US dollars in investments
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Bionter receives 3 million US dollars in investments

Bionter AG has received 3 million US dollars in a seed funding round. These funds will enable Bionter to bring...

Read More
Resistell seeking to further develop test to combat antibiotic resistance
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Resistell seeking to further develop test to combat antibiotic resistance

The startup Resistell has launched a study looking into the applicability of a test against antibiotic resistances that is being...

Read More
Biotech startup Cimeio receives 46 million Swiss francs for cell therapy
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech

Biotech startup Cimeio receives 46 million Swiss francs for cell therapy

Cimeio Therapeutics from Basel has received initial financing amounting to 46 million Swiss francs from Versant Ventures. The startup is...

Read More
Superlab Suisse heading to Basel
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Medtech

Superlab Suisse heading to Basel

Superlab Suisse is bringing its Lab-as-a-Service business concept to Basel. The company will open a new location with lab and...

Read More
Swiss TPH opens new building on the site of BaseLink
Basel Area Business & Innovation, Innovation, Invest, Life Sciences / biotech, Switzerland Innovation Park

Swiss TPH opens new building on the site of BaseLink

The Swiss Tropical and Public Health Institute has officially opened its multifunctional new building at the Basel Area’s new life...

Read More
World first in the Switzerland Innovation Park Basel Area
Basel Area Business & Innovation, Innovation, Switzerland Innovation Park

World first in the Switzerland Innovation Park Basel Area

Eldico Scientific has opened the world’s first experience center for electron diffractometry in the site Allschwil of the Switzerland Innovation...

Read More
DayOne healthtech accelerator launches new offering
Basel Area Business & Innovation, Digital Health, Innovation, Medtech

DayOne healthtech accelerator launches new offering

DayOne shares the launch of DayOne Accelerator 2.0, marking a transition to three verticals that will enable the growth of...

Read More
1 2 3 33

Do you have a question? We'd like to hear from you.